Personalized Genomics Market
完整報告名稱與涵蓋範圍
Personalized Genomics Market Size, Share & Trends Analysis Report By Cancer Type (Lung Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Bladder Cancer and Others (Melanoma, Kidney cancer, Ovarian cancer etc.)), By Target, By Therapy, By End User, By Region, And By Segment Forecasts, 2023-2031.
報告摘要
The worldwide Personalized Genomics Market stood at USD 7.97 Billion in 2022, and is expected to reach USD 32.15 Billion by 2031, recording a CAGR of 16.96% from 2023 through 2031.
At its core, Personalized Genomics pertains to landscape are risingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by rising appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Personalized Genomics Market Snapshot
Chapter 4. Global Personalized Genomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. By Test Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Test Type:
5.2.1. Oncology Testing
5.2.2. Infectious Disease Testing
5.2.3. Neurological Testing
5.2.4. Cardiovascular Testing
5.2.5. Others
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Technology:
6.2.1. PCR-based Tests
6.2.2. Microarray-based Tests
6.2.3. Sequencing-based Tests
6.2.4. Others
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By Application:
7.2.1. Diagnostics
7.2.2. Precision Medicine
7.2.3. Wellness
7.2.4. Reproductive Health
7.2.5. Sports Nutrition & Health Lifestyle
7.2.6. Others
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. By End User & Market Share, 2019 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 for the following By End User:
8.2.1. Hospitals & Clinics
8.2.2. Research Centers
8.2.3. Pharmaceutical & Biotechnology Companies
8.2.4. Diagnostic Laboratories,
8.2.5. Others
Chapter 9. Personalized Genomics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Test Type, 2023- 2031
9.1.2. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Technology, 2023- 2031
9.1.3. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By Application, 2023- 2031
9.1.4. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts By End User, 2023- 2031
9.1.5. North America Personalized Genomics Market revenue (US$ Million) estimates and forecasts by country, 2023- 2031
9.2. Europe
9.2.1. Europe Personalized Genomics Market revenue (US$ Million) By Test Type, 2023- 2031
9.2.2. Europe Personalized Genomics Market revenue (US$ Million) By Technology, 2023- 2031
9.2.3. Europe Personalized Genomics Market revenue (US$ Million) By Application, 2023- 2031
9.2.4. Europe Personalized Genomics Market revenue (US$ Million) By End User, 2023- 2031
9.2.5. Europe Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.3. Asia Pacific
9.3.1. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Test Type, 2023- 2031
9.3.2. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Technology, 2023- 2031
9.3.3. Asia Pacific Personalized Genomics Market revenue (US$ Million) By Application, 2023- 2031
9.3.4. Asia Pacific Personalized Genomics Market revenue (US$ Million) By End User, 2023- 2031
9.3.5. Asia Pacific Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.4. Latin America
9.4.1. Latin America Personalized Genomics Market revenue (US$ Million) By Test Type, (US$ Million) 2023- 2031
9.4.2. Latin America Personalized Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2023- 2031
9.4.3. Latin America Personalized Genomics Market revenue (US$ Million) By Application, (US$ Million) 2023- 2031
9.4.4. Latin America Personalized Genomics Market revenue (US$ Million) By End User, (US$ Million) 2023- 2031
9.4.5. Latin America Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Test Type, (US$ Million) 2023- 2031
9.5.2. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Technology, (US$ Million) 2023- 2031
9.5.3. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By Application (US$ Million) 2023- 2031
9.5.4. Middle East & Africa Personalized Genomics Market revenue (US$ Million) By End User, (US$ Million) 2023- 2031
9.5.5. Middle East & Africa Personalized Genomics Market revenue (US$ Million) by country, 2023- 2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. 23andMe,
10.2.2. Mapmygenome,
10.2.3. Invitea,
10.2.4. Genetic Technology Limited,
10.2.5. Lonza,
10.2.6. Interleukin Genetics, Inc,
10.2.7. GNA Genotek,
10.2.8. Helix,
10.2.9. MyHeritage,
10.2.10. Pathway Genomics,
10.2.11. Veritas Genetics,
10.2.12. Xcode,
10.2.13. Color Genomics,
10.2.14. Myriad Genetics,
10.2.15. Quest Diagnostics,
10.2.16. Bio-Rad Laboratories, Inc.,
10.2.17. Illumina,
10.2.18. Thermo Fisher Scientific,
10.2.19. Qiagen,
10.2.20. Genomic Health,
10.2.21. Nebula Genomics
10.2.22. Eastern Biotech and Life Sciences,
10.2.23. uBiome, Inc
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們